{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:15Z","timestamp":1789516815872,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Treatment of cutaneous leishmaniasis (CL) remains a major challenge for the public health and medical community. It has been claimed that natural compounds derived from fly larvae have anti-leishmania properties against some species of <jats:italic>Leishmania<\/jats:italic>. The present study aimed at assessing the in vitro effects of larval products of <jats:italic>Lucilia sericata<\/jats:italic> against the promastigote and intracellular amastigote forms of <jats:italic>Leishmania major<\/jats:italic>. Also, the therapeutic effect of larval products on lesions induced by <jats:italic>L. major<\/jats:italic> infection was evaluated in BALB\/c mice models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Parasite specimens and macrophage cells were exposed to varying concentrations of larval products for 24\u2013120\u00a0h. Lesion progression and parasite load were investigated in the models to assess the therapeutic effects of the products.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The larval products displayed more potent cytotoxicity against <jats:italic>L. major<\/jats:italic> promastigotes. The IC<jats:sub>50<\/jats:sub> values for larval saliva and hemolymph were 100.6 and 37.96\u00a0ug\/ml, respectively. The IC<jats:sub>50<\/jats:sub> of glucantime was 9.480\u00a0ug\/ml. Also, the saliva and hemolymph of <jats:italic>L. sericata<\/jats:italic> exhibited higher cytotoxicity against the promastigotes of <jats:italic>L. major<\/jats:italic> but were less toxic to the macrophage cells. Treatment with leishmanicidal agents derived from larvae of <jats:italic>L. sericata<\/jats:italic> decreased the infection rate and the number of amastigotes per infected host cell at all concentrations. Lesion size was significantly (<jats:italic>F<\/jats:italic><jats:sub>(7, 38)<\/jats:sub>\u2009=\u20098.54, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) smaller in the treated mice compared with the untreated control group. The average parasite burden in the treated mice groups (1.81\u2009\u00b1\u20090.74, 1.03\u2009\u00b1\u20090.45 and 3.37\u2009\u00b1\u20090.41) was similar to the group treated with a daily injection of glucantime (1.77\u2009\u00b1\u20090.99) and significantly lower (<jats:italic>F<\/jats:italic><jats:sub>(7, 16)<\/jats:sub>\u2009=\u200966.39, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) than in the untreated control group (6.72\u2009\u00b1\u20092.37).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The results suggest that the larval products of <jats:italic>L. sericata<\/jats:italic> were effective against <jats:italic>L. major<\/jats:italic> parasites both in vivo and in vitro. However, more clinical trial studies are recommended to evaluate the effects of these larval products on human subjects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13071-023-05660-0","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T16:02:31Z","timestamp":1676563351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The therapeutic effect of larval saliva and hemolymph of Lucilia sericata on the treatment of Leishmania major lesion in BALB\/c mice946"],"prefix":"10.1186","volume":"16","author":[{"given":"Sara","family":"Rahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Rafinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Ahmad","family":"Akhavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Ahmadkhaniha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Bakhtiyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Khamesipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Akbarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"5660_CR1","unstructured":"Centers for Disease Control and Prevention 2020 [Internet]. [cited 2020 Feb 18]. https:\/\/www.cdc.gov\/parasites\/."},{"key":"5660_CR2","unstructured":"World Health Organization 2021 [Internet]. [cited 2021 May 20]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis."},{"key":"5660_CR3","first-page":"7","volume":"107","author":"BS McGwire","year":"2014","unstructured":"McGwire BS, Satoskar A. Leishmaniasis: clinical syndromes and treatment. Int J Med. 2014;107:7\u201314.","journal-title":"Int J Med"},{"key":"5660_CR4","first-page":"1","volume":"2015","author":"JPB De Menezes","year":"2015","unstructured":"De Menezes JPB, Guedes CES, Petersen ALdOA, Fraga DBM, Veras PST. Advances in the development of new treatments for leishmaniasis. Biomed Res Int. 2015;2015:1\u201311.","journal-title":"Biomed Res Int"},{"key":"5660_CR5","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/S0140-6736(16)31460-X","volume":"388","author":"NJ Kassebaum","year":"2016","unstructured":"Kassebaum NJ, Arora M, Barber RM, Bhutta ZA, Brown J, Carter A, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990\u20132015: a systematic analysis for the Global burden of disease study 2015. Lancet. 2016;388:1603\u201358.","journal-title":"Lancet"},{"key":"5660_CR6","unstructured":"World Health Organization 2020 [Internet]. [cited 2020 Jun 17]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis."},{"key":"5660_CR7","first-page":"429","volume":"10","author":"MR Yaghoobi-Ershadi","year":"2016","unstructured":"Yaghoobi-Ershadi MR. Control of phlebotomine sand flies in Iran: a review article. J Arthropod Borne Dis. 2016;10:429\u201344.","journal-title":"J Arthropod Borne Dis"},{"key":"5660_CR8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMicm1908092","volume":"382","author":"AP Knapp","year":"2020","unstructured":"Knapp AP, Alpern JD. Cutaneous leishmaniasis. N Engl J Med. 2020;382:e2.","journal-title":"N Engl J Med"},{"key":"5660_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ijid.2011.03.021","volume":"15","author":"TS Truman","year":"2011","unstructured":"Truman TS, Santos AO, Ueda-Nakamura T, Dias Filho BP, Nakamura CV. Recent advances in leishmaniasis treatment. Int J Infect Dis. 2011;15:525\u201332.","journal-title":"Int J Infect Dis"},{"key":"5660_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13071-019-3323-0","volume":"12","author":"NF Dos Santos","year":"2019","unstructured":"Dos Santos NF, Avino VC, Galvis-Ovallos F, Pereira-Chioccola VL, Moreira MAB, Romariz APPL, et al. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil. Parasit Vect. 2019;12:79.","journal-title":"Parasit Vect"},{"key":"5660_CR11","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1111\/jdv.14434","volume":"32","author":"N Kn\u00f6pfel","year":"2018","unstructured":"Kn\u00f6pfel N, Noguera Morel L, Azorin D, Sanz F, Torrelo A, Hern\u00e1ndez MA. Cutaneous Leishmania tropica in children: report of three imported cases successfully treated with liposomal amphotericin B. Journal J Eur Acad Dermatol Venereol. 2018;32:e8-10.","journal-title":"Journal J Eur Acad Dermatol Venereol"},{"key":"5660_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ejmech.2012.01.046","volume":"50","author":"A Tahghighi","year":"2012","unstructured":"Tahghighi A, Ramzi S, Mahdavi M, Foroumadi P, Ardestani SK, Emami S, et al. Synthesis and anti-leishmanial activity of 5-(5-nitrofuran-2-yl)-1, 3, 4-thiadiazol-2-amines containing N-[(1-benzyl-1H-1, 2, 3-triazol-4-yl) methyl] moieties. Eur J Med Chem. 2012;50:124\u20138.","journal-title":"Eur J Med Chem"},{"key":"5660_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.actatropica.2004.03.009","volume":"91","author":"RX Armijos","year":"2004","unstructured":"Armijos RX, Weigel MM, Calvopi\u00f1a M, Mancheno M, Rodriguez R. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta Trop. 2004;91:153\u201360.","journal-title":"Acta Trop"},{"key":"5660_CR14","doi-asserted-by":"publisher","DOI":"10.5812\/jjnpp.106431","volume":"16","author":"M Ahmadi","year":"2021","unstructured":"Ahmadi M, Akhbari Z, Zamani Z, Hajhossieni R, Arjmand M. Study the mechanism of antileishmanial action of Xanthium strumarium against amastigotes stages in Leishmania major: a metabolomics approach. Jundishapur J Nat Pharm Prod. 2021;16:e106431.","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"5660_CR15","first-page":"1","volume":"949","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Control of the leishmaniases. World Health Organ Tech Rep Ser. 2010;949:1\u2013186.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"5660_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ibmb.2011.05.007","volume":"41","author":"NA Ratcliffe","year":"2011","unstructured":"Ratcliffe NA, Mello CB, Garcia ES, Butt TM, Azambuja P. Insect natural products and processes: new treatments for human disease. Insect Biochem Mol Biol. 2011;41:747\u201369.","journal-title":"Insect Biochem Mol Biol"},{"key":"5660_CR17","first-page":"124","volume":"15","author":"EP Cherniack","year":"2010","unstructured":"Cherniack EP. Bugs as drugs, part 1: insects: the \u201cnew\u201d alternative medicine for the 21st century. Altern Med Rev. 2010;15:124\u201335.","journal-title":"Altern Med Rev"},{"key":"5660_CR18","doi-asserted-by":"publisher","first-page":"358","DOI":"10.12980\/APJTB.4.2014C1134","volume":"4","author":"I Valachova","year":"2014","unstructured":"Valachova I, Prochazka E, Bohova J, Novak P, Takac P, Majtan J. Antibacterial properties of luciferin in Lucilia sericata maggots after septic injury. Asian Pac J Trop Biomed. 2014;4:358\u201361.","journal-title":"Asian Pac J Trop Biomed"},{"key":"5660_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-0711-10-6","volume":"10","author":"S Arora","year":"2011","unstructured":"Arora S, Baptista C, Lim CS. Maggot metabolites and their combinatory effects with antibiotic on Staphylococcus aureus. Ann Clin Microbiol Antimicrob. 2011;10:1\u20138.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"5660_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.exppara.2012.06.004","volume":"132","author":"E Polat","year":"2012","unstructured":"Polat E, Cakan H, Aslan M, Sirekbasan S, Kutlubay Z, Ipek T, et al. Detection of the anti-leishmanial effect of the Lucilia sericata larval secretions in vitro and in vivo on Leishmania tropica: first work. Exp Parasitol. 2012;132:129\u201334.","journal-title":"Exp Parasitol"},{"key":"5660_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.actatropica.2017.09.033","volume":"177","author":"MJ Laverde-Paz","year":"2018","unstructured":"Laverde-Paz MJ, Echeverry MC, Patarroyo MA, Bello FJ. Evaluating the anti-leishmania activity of Lucilia sericata and Sarconesiopsis magellanica blowfly larval excretions\/secretions in an in vitro model. Acta trop. 2018;177:44\u201350.","journal-title":"Acta trop"},{"key":"5660_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/WON.0000000000000496","volume":"46","author":"A Malekian","year":"2019","unstructured":"Malekian A, Djavid GE, Akbarzadeh K, Soltandallal M, Rassi Y, Rafinejad J, et al. Efficacy of maggot therapy on Staphylococcus aureus and Pseudomonas aeruginosa in diabetic foot ulcers: a randomized controlled trial. J Wound Ostomy Continence Nurs. 2019;46:25\u20139.","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"5660_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1515\/hsz-2013-0263","volume":"395","author":"A-K P\u00f6ppel","year":"2014","unstructured":"P\u00f6ppel A-K, Koch A, Kogel K-H, Vogel H, Kollewe C, Wiesner J, et al. Lucimycin, an antifungal peptide from the therapeutic maggot of the common green bottle fly Lucilia sericata. Biol Chem. 2014;395:649\u201356.","journal-title":"Biol Chem"},{"key":"5660_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02791","volume":"5","author":"MR Abdel-Samad","year":"2019","unstructured":"Abdel-Samad MR. Antiviral and virucidal activities of Lucilia cuprina maggots\u2019 excretion\/secretion (diptera: calliphoridae): first work. Heliyon. 2019;5:e02791.","journal-title":"Heliyon"},{"key":"5660_CR25","doi-asserted-by":"publisher","first-page":"040","DOI":"10.1093\/femspd\/ftab040","volume":"79","author":"ACJ Rodrigues","year":"2021","unstructured":"Rodrigues ACJ, Bortoleti BTdS, Carloto ACM, Silva TF, Concato VM, Gon\u00e7alves MD, et al. Larval excretion\/secretion of Diptera of Lucilia cuprina species induces death in promastigote and amastigote forms of Leishmania amazonensis. Pathog Dis. 2021;79:040.","journal-title":"Pathog Dis"},{"key":"5660_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.exppara.2016.08.007","volume":"170","author":"A Sanei-Dehkordi","year":"2016","unstructured":"Sanei-Dehkordi A, Khamesipour A, Akbarzadeh K, Akhavan AA, Mohammadi AMA, Mohammadi Y, et al. Anti-leishmania activity of Lucilia sericata and Calliphora vicina maggots in laboratory models. Exp Parasitol. 2016;170:59\u201365.","journal-title":"Exp Parasitol"},{"key":"5660_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.7705\/biomedica.v28i2.102","volume":"28","author":"J Arrivillaga","year":"2008","unstructured":"Arrivillaga J, Rodr\u00edguez J, Oviedo M. Preliminary evaluation of maggot (Diptera: Calliphoridae) therapy as a potential treatment for leishmaniasis ulcers. Biomedica. 2008;28:305\u201310.","journal-title":"Biomedica"},{"key":"5660_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13071-020-04543-y","volume":"14","author":"S Rahimi","year":"2021","unstructured":"Rahimi S, Akhavan AA, Rafinejad J, Ahmadkhaniaha R, Bakhtiyari M, Veysi A, et al. The leishmanicidal effect of Lucilia sericata larval saliva and hemolymph on in vitro Leishmania tropica. Parasit Vect. 2021;14:40.","journal-title":"Parasit Vect"},{"key":"5660_CR29","first-page":"197","volume":"43","author":"LC Rueda","year":"2010","unstructured":"Rueda LC, Ortega LG, Segura NA, Acero VM, Bello F. Lucilia sericata strain from Colombia: experimental colonization, life tables and evaluation of two artificial diets of the blowfly Lucilia sericata (Meigen) (Diptera: Calliphoridae), Bogot\u00e1. Colombia Strain Biol Res. 2010;43:197\u2013203.","journal-title":"Colombia Strain Biol Res"},{"key":"5660_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/jac\/dkm407","volume":"61","author":"MJ Van der Plas","year":"2008","unstructured":"Van der Plas MJ, Jukema GN, Wai S-W, Dogterom-Ballering HC, Lagendijk EL, Van Gulpen C, et al. Maggot excretions\/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother. 2008;61:117\u201322.","journal-title":"J Antimicrob Chemother"},{"key":"5660_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1017\/S003118200400681X","volume":"130","author":"I Rohousova","year":"2005","unstructured":"Rohousova I, Ozensoy S, Ozbel Y, Volf P. Detection of species-specific antibody response of humans and mice bitten by sand flies. Parasitol. 2005;130:493\u20139.","journal-title":"Parasitol"},{"key":"5660_CR32","volume-title":"Immune response of great gerbil against Phlebotomus papatasi saliva","author":"A Akhavan","year":"2011","unstructured":"Akhavan A. Immune response of great gerbil against Phlebotomus papatasi saliva. Saarbr\u00fccken: Lap Lambert Academic Publishing; 2011."},{"key":"5660_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.toxicon.2008.05.008","volume":"52","author":"AG Tempone","year":"2008","unstructured":"Tempone AG, Pimenta DC, Lebrun I, Sartorelli P, Taniwaki NN, de Andrade Jr HF, et al. Antileishmanial and antitrypanosomal activity of bufadienolides isolated from the toad rhinella jimi parotoid macrogland secretion. Toxicon. 2008;52:13\u201321.","journal-title":"Toxicon"},{"key":"5660_CR34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3923\/rjmp.2009.61.68","volume":"3","author":"PK Ngure","year":"2009","unstructured":"Ngure PK, Tonui WK, Ingonga J, Mutai C, Kigondu E, Ngrsquo Z, et al. In vitro antileishmanial activity of extracts of Warburgia ugandensis (Canellaceae), a Kenyan medicinal plant. J Med Plant Res. 2009;3:61\u20136.","journal-title":"J Med Plant Res"},{"key":"5660_CR35","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.976","volume":"3","author":"M Lu","year":"2013","unstructured":"Lu M, Varley AW. Harvest and culture of mouse peritoneal macrophages. Bio-Protoc. 2013;3:e976.","journal-title":"Bio-Protoc"},{"key":"5660_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/imrn\/rnr003","volume":"2012","author":"M Garc\u00eda","year":"2012","unstructured":"Garc\u00eda M, Monzote L, Scull R, Herrera P. Activity of cuban plants extracts against Leishmania amazonensis. Int sch res notices. 2012;2012:1\u20137.","journal-title":"Int sch res notices"},{"key":"5660_CR37","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1128\/AAC.39.9.2167","volume":"39","author":"P Buffet","year":"1995","unstructured":"Buffet P, Sulahian A, Garin Y, Nassar N, Derouin F. Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother. 1995;39:2167\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"5660_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijpddr.2020.08.002","volume":"14","author":"L Herrera","year":"2020","unstructured":"Herrera L, Llanes A, \u00c1lvarez J, Degracia K, Restrepo CM, Rivera R, et al. Antileishmanial activity of a new chloroquine analog in an animal model of Leishmania panamensis infection. Int J Parasitol Drugs Drug Resist. 2020;14:56\u201361.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5660_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","volume":"7","author":"RG Titus","year":"1985","unstructured":"Titus RG, Marchand M, Boon T, Louis J. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 1985;7:545\u201355.","journal-title":"Parasite Immunol"},{"key":"5660_CR40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.exppara.2008.12.015","volume":"121","author":"A Badiee","year":"2009","unstructured":"Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Kheiri MT, et al. The role of liposome charge on the immune response generated in BALB\/c mice immunized with recombinant major surface glycoprotein of Leishmania. Exp Parasitol. 2009;121:362\u20139.","journal-title":"Exp Parasitol"},{"key":"5660_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.actatropica.2016.09.020","volume":"164","author":"L Cruz-Saavedra","year":"2016","unstructured":"Cruz-Saavedra L, D\u00edaz-Roa A, Gaona MA, Cruz ML, Ayala M, Cort\u00e9s-Vecino JA, et al. The effect of Lucilia sericata and Sarconesiopsis magellanica-derived larval therapy on Leishmania panamensis. Acta Trop. 2016;164:280\u20139.","journal-title":"Acta Trop"},{"key":"5660_CR42","first-page":"893","volume":"48","author":"A Mirzapour","year":"2019","unstructured":"Mirzapour A, Spotin A, Behniafar H, Azizi H, Maleki B, Shakeraminia H, et al. Intra-species diversity of Leishmania major and Leishmania tropica from clinical isolates of cutaneous leishmaniasis in South-west Iran inferred by ITS1-rDNA. Iran J Public Health. 2019;48:893\u2013901.","journal-title":"Iran J Public Health"},{"key":"5660_CR43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1529\/biophysj.108.139154","volume":"96","author":"J Lam","year":"2009","unstructured":"Lam J, Herant M, Dembo M, Heinrich V. Baseline mechanical characterization of J774 macrophages. Biophys J. 2009;96:248\u201354.","journal-title":"Biophys J"},{"key":"5660_CR44","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1365-4632.2006.02822.x","volume":"45","author":"R Salmanpour","year":"2006","unstructured":"Salmanpour R, Razmavar MR, Abtahi N. Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis. Int J Dermatol. 2006;45:1115\u20136.","journal-title":"Int J Dermatol"},{"key":"5660_CR45","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1159\/000237741","volume":"16","author":"L Monzote","year":"2009","unstructured":"Monzote L, Garcia M, Montalvo AM, Linares R, Scull R. Effect of oral treatment with the essential oil from Chenopodium ambrosioides against cutaneous leishmaniasis in BALB\/c mice, caused by Leishmania amazonensis. J Complement Med Res. 2009;16:334\u20138.","journal-title":"J Complement Med Res"},{"key":"5660_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41684-021-00871-3","volume":"50","author":"S Ahmadi-Noorbakhsh","year":"2021","unstructured":"Ahmadi-Noorbakhsh S, Mirabzadeh Ardakani E, Sadighi J, Aldavood SJ, Farajli Abbasi M, Farzad-Mohajeri S, et al. Guideline for the care and use of laboratory animals in Iran. Lab Anim. 2021;50:303\u20135.","journal-title":"Lab Anim"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05660-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-023-05660-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05660-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T17:04:00Z","timestamp":1676567040000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-023-05660-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5660"],"URL":"https:\/\/doi.org\/10.1186\/s13071-023-05660-0","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"assertion":[{"value":"1 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Tehran University of Medical Sciences approved all protocols described in the current study (IR.TUMS. 1396.4207). BALB\/c mice were purchased from Pasteur Institute and maintained in the Center for Research and Training in Skin Disease and Leprosy (CRTSDL), TUMS. The mice were housed at a maximum of five per cage and maintained in a conventional room (23\u2009\u00b1\u20092\u00a0\u00b0C, relative humidity: 65%, with 12\u00a0h light-dark cycles). The mice were provided tap water and laboratory pellet chow and were fed ad libitum. Studies in <i>L. major<\/i>-infected BALB\/c mice were performed following the guidelines for the care and use of laboratory animals in Iran [].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have given full consent to publish the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have stated explicitly that there are no conflicts of interest in connection with this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}